Serum lipid levels for a multicultural population in Auckland, New Zealand: Results from the diabetes heart and health survey (DHAH) 2002-2003

New Zealand Medical Journal

Volumn 120, Issue 1265, 2007, Pages

  Gentles, Dudley ^a   Metcalf, Patricia ^a   Dyall, Lorna ^a   Scragg, Robert ^a   Sundborn, Gerhard ^a   Schaaf, David ^a   Black, Peter N ^a   Jackson, Rodney T ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPID;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; COOK ISLANDS; CULTURAL ANTHROPOLOGY; DIABETES MELLITUS; DIET RESTRICTION; DYSLIPIDEMIA; ETHNIC DIFFERENCE; FEMALE; GENDER; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; LEISURE; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; OBESITY; PHYSICAL ACTIVITY; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; SAMOA; TONGA; TRIACYLGLYCEROL BLOOD LEVEL; ABORIGINE; AGE DISTRIBUTION; BLOOD; CAUCASIAN; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; ETHNOLOGY; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; SEX RATIO; STATISTICS;

ADULT; AGE DISTRIBUTION; AGED; ANTILIPEMIC AGENTS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; NEW ZEALAND; OCEANIC ANCESTRY GROUP; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; SEX DISTRIBUTION; TRIGLYCERIDES;

EID: 37249042656     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293-8.
2. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-47.
3. Corvol JC, Bouzamondo A, Sirol M, et al. Differential effects of lipid-lowering therapies on stroke prevention: A meta-analysis of randomized trials. Arch Intern Med. 2003;163:669-76. Review
4. Capewell S, Beaglehole R, Seddon M, McMurray J. Explanation for the Decline in Coronary Heart Disease Mortality Rates in Auckland, New Zealand, Between 1982 and 1993. Circulation. 2000;102:1511-6.
5. Metcalf PA, Scragg RRK, Schaaf D, et al. Trends in major cardiovascular risk factors in Auckland, New Zealand: 1982 to 2002-2003. N Z Med J. 2006;199(1245). http://www.nzma.org.nz/journal/19-1245/2308
6. Metcalf PA, Scragg RK, Swinburn BA, Shaw LM. Factors associated with changes in serum total cholesterol levels over 7 years in middle-aged New Zealand men and women: A prospective study. Nutr Metab Cardiovasc Dis. 2001;11:298-305.
7. Evans A, Tolonen H, Hense H-W, et al. Trends in coronary risk factors in the WHO MONICA Project10.1093/ije/30.suppl_1.S35. Int J Epidemiol. 2001;30:S35-40.
8. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994;308:367-72.
9. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-78. Erratum in Lancet. 2005;366:1358.
10. Manninen V, Elo MO, Frick MH, et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA. 1988;260:641-51.
11. Criqui MH, Golomb BA. Epidemiologic aspects of lipid abnormalities. Am J Med. 1998;105:48S-57S. Review
12. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213-9.
13. Abdel-Maksoud MF, Hokanson JE. The complex role of triglycerides in cardiovascular disease. Seminars in Vascular Medicine. 2002;2:325-33. Review
14. Austin MA, Hokanson, John E., Edwards KL. Hypertriglyceridemia as a Cardiovascular Risk Factor. The American Journal of Cardiology. 1998;81:7B-12B.
15. Scragg R, Baker J, Metcalf P, Dryson E. Serum lipid levels in a New Zealand multicultural workforce. N Z Med J. 1993;106:96-9.
16. Jackson RT, Beaglehole R, Stewart AW. Blood pressure levels and the treatment of hypertension in Auckland, 1982. N Z Med J. 1983;96:751-4.
17. Trye P, Jackson R, Stewart A, et al. Trends and determinants of blood pressure in Auckland, New Zealand 1982-94. N Z Med J. 1996;109:179-81.
18. Bullen C, Simmons G, Trye P, et al. Cardiovascular disease risk factors in 65-84 year old men and women: Results from the Auckland University Heart and Health Study 1993-4. N Z Med J. 1998; 111:4-7.
19. Metcalf PA, Scragg RKR, Jackson RT. Cardiovascular disease risk factor levels of Asians living in Auckland: Results from the Diabetes, Heart and Health Survey. In: Tse S, Hoque ME, Rasanathan K, Chatterji M, Wee R, Garg S, Ratnasabapathy Y, editors. Prevention, protection and promotion. Proceedings of the Second International Asian Health and Wellbeing Conference.; 2006 11,13-14 Nov; Auckland, New Zealand: University of Auckland; 2006. p. 41-9.
20. Metcalf PA, Scott A, Hutchinson R. Dual frame estimation for a survey with a complex design. In: 55th Session of the International Statistical Institute; 2005; Sydney Australia; 2005.
21. Swinburn BA, Ley SJ, Carmichael HE, Plank LD. Body size and composition in Polynesians. Int J Obes Relat Metab Disord. 1999;23:1178-83.
22. New Zealand Guidelines Group. The assessment and management of cardiovascular risk. Wellington: NZGG; 2003. URL: http://www.nz.nzgg.org.nz/guidelines/ dsp_guideline_popup.cfm?guidelineID=35
23. Diagnostic laboratory handbook: A handbook for the interpretation of laboratory tests. Diagnostic Medlab Ltd, 2000. http://www.dml.co.nz/ downloads/1273_handbook.fdf
24. National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
25. Cholesterol. The National Heart Foundation of New Zealand, 2005. http://www.nhf.org.nz/files/Cardiac_Care/Resources/ NHF8584%20Cholesterol.pdf
26. Jackson R, Chambless LE, Yang K, et al. Differences between respondents and nonrespondents in a multicenter community-based study vary by gender and ethnicity. J Clin Epidemiol. 1996;49:1441-6.
27. World Health Organization. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva: WHO; 2004. http://www.who.int/publications/cra/ chapters/volume1/0391-0496.pdf
28. Skeaff CM, Mann JI, McKenzie J, et al. Declining levels of total serum cholesterol in adult New Zealanders. N Z Med J. 2001;114:131-4.
29. Mann JI, Duncan A, Ball MJ, et al. Blood lipid levels in New Zealand. N Z Med J. 1991;104:371-4.
30. Stamford BA, Matter S, Fell RD, et al. Cigarette smoking, exercise and high density lipoprotein cholesterol. Atherosclerosis. 1984;52:73-83.
31. Rimm EB, Williams P, Fosher K, et al. Moderate alcohol intake and lower risk of coronary heart disease: Meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999;319:1523-8.
32. Durstine JL, Grandjean PW, Cox CA, Thompson PD. Lipids, lipoproteins, and exercise. J Cardpulm Rehabil. 2002;22:385-98. Review
33. Fruchart JC, Duriez P. HDL and triglyceride as therapeutic targets. Curr Opin Lipidol. 2002;13:605-16. Review
34. Simons LA, Simons J, Jones AS. The interactions of body weight, age, cigarette smoking and hormone usage with blood pressure and plasma lipids in an Australian community. Aust N Z J Med. 1984;14:215-21.